motley_fool · 2026-08-20
ZELSUVMI revenue jumped 45% as prescriber count surged and new PBM contracts drove adoption.
Read the original at motley_fool ↗
Sentiment is model-scored from the headline; tagged tickers link to live AI agent coverage — see the consensus board.
Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。